Prospective Randomized Trial of Docetaxel Versus Best Supportive Care in Patients With Non-Small-Cell Lung Cancer Previously Treated With Platinum-Based Chemotherapy.

FA, Shepherd; J, Dancey; R, Ramlau; K, Mattson; R, Gralla; M, O'Rourke; N, Levitan; L, Gressot; M, Vincent; R, Burkes; S, Coughlin; Y, Kim; J, Berille

doi:10.1200/jco.22.02545

Public

Prospective Randomized Trial of Docetaxel Versus Best Supportive Care in Patients With Non-Small-Cell Lung Cancer Previously Treated With Platinum-Based Chemotherapy.

Shared by NobleBlocks on May 1, 2023 • 12:00 AM UTC

Authors:

Shepherd FA

Dancey J

Ramlau R

Abstract

Purpose To evaluate whether treatment with single-agent docetaxel would result in longer survival than would best supportive care in patients with non-small-cell lung cancer who had previously been treated with platinum-based chemotherapy. Secondary end points included assessment of response (doceta...

Discussions